Krka d.d. Novo mesto

Krka d.d. Novo mesto is Slovenia's largest pharmaceutical company and one of the leading generic pharmaceutical manufacturers in Central and Eastern Europe, headquartered at Šmarješka cesta 6 in Novo Mesto, the capital of the Dolenjska region in southeastern Slovenia along the Krka river. Founded in 1954 and named after the river, Krka employs over 12,500 staff across production sites in Novo Mesto (Ločna and Bršljin), Krško, Šentjernej, Ljutomer, and offices in Ljubljana, with international subsidiaries and representative offices in over 70 countries. Krka is listed on the Ljubljanska borza (Ljubljana Stock Exchange) and the Warsaw Stock Exchange, and is one of the most valuable publicly traded companies in Slovenia. Krka's in-house legal division is among the largest corporate legal teams in the Slovenian pharmaceutical sector, handling intellectual property and patent strategy across multiple jurisdictions including European Patent Office (EPO) oppositions and Unified Patent Court (UPC) proceedings, pharmaceutical regulatory compliance under the Zakon o zdravilih (ZZdr-2, Medicinal Products Act) and EU pharmaceutical legislation, marketing authorisation procedures through EMA and national agencies, clinical trial regulations under the EU Clinical Trials Regulation (CTR), competition law matters including reverse payment settlement scrutiny, complex supply chain and manufacturing contracts, GDPR and pharmacovigilance data compliance, environmental regulation under the Zakon o varstvu okoliša (ZVO-2, Environmental Protection Act), and employment law for a multinational workforce under ZDR-1 and local labour codes across its international operations.